Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jan 28;17(1):e1003035.
doi: 10.1371/journal.pmed.1003035. eCollection 2020 Jan.

Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?

Karin Sundström  1 , K Miriam Elfström  1   2
Affiliations
Editorial

Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?

Karin Sundström et al. PLoS Med. .

Abstract

With major advances in understanding the infectious etiology of cervical cancer, preventive medicine has obtained highly promising new tools. Human papillomavirus (HPV) vaccines, together with a growing arsenal of HPV-based screening tests, have the potential to radically change public health but require diligent, large-scale implementation to reach the final goal: the elimination of cervical cancer. We reflect here upon the state of cervical cancer prevention globally as there have been several recent developments that will inform this implementation process.

PubMed Disclaimer

Conflict of interest statement

We have read the journal’s policy and the authors of this manuscript have the following competing interests: KS has received research grants to her institution from Merck and Co., Inc. and MSD Sweden for register-based studies on HPV vaccination in Sweden. ME has no conflicts.

References

    1. Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019;68:698–702. 10.15585/mmwr.mm6832a3 - DOI - PMC - PubMed
    1. National Health Service, United Kingdom. Decision based on the report from The Joint Committee on Vaccination and Immunisation in 2017. [cited 2019 Dec 18]. Available from: https://www.nhs.uk/conditions/vaccinations/hpv-human-papillomavirus-vacc...
    1. International Agency for Research on Cancer. Biological Agents. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 100B Lyon, France, 2012. p. 270–75.
    1. Lehtinen M, Dillner J. Clinical trials of human papillomavirus vaccines and beyond. Nat Rev Clin Oncol. 2013;10(7):400–10. 10.1038/nrclinonc.2013.84 - DOI - PubMed
    1. Drolet M, Bénard É, Pérez N, Brisson M; HPV Vaccination Impact Study Group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497–509. 10.1016/S0140-6736(19)30298-3 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances